{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:04:39Z","timestamp":1786997079752,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.spen.2006.06.006","type":"journal-article","created":{"date-parts":[[2006,10,10]],"date-time":"2006-10-10T07:25:09Z","timestamp":1160465109000},"page":"104-114","source":"Crossref","is-referenced-by-count":35,"title":["The Childhood Limb-Girdle Muscular Dystrophies"],"prefix":"10.1016","volume":"13","author":[{"given":"Volker","family":"Straub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Bushby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2006.06.006_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/spen.2002.33795","article-title":"Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies","volume":"9","author":"B\u00f6nnemann","year":"2002","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.spen.2006.06.006_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/0470093765.ch8","article-title":"Muscular dystrophies related to the cytoskeleton\/nuclear envelope","volume":"264","author":"Nowak","year":"2005","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.spen.2006.06.006_bib3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s001090100225","article-title":"Pathophysiology of limb girdle muscular dystrophy type 2A: Hypothesis and new insights into the IkappaBalpha\/NF-kappaB survival pathway in skeletal muscle","volume":"79","author":"Baghdiguian","year":"2001","journal-title":"J Mol Med"},{"key":"10.1016\/j.spen.2006.06.006_bib4","first-page":"64","article-title":"Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies","volume":"24","author":"Endo","year":"2005","journal-title":"Acta Myol"},{"key":"10.1016\/j.spen.2006.06.006_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/339083","article-title":"Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene","volume":"70","author":"Frosk","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2006.06.006_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/72822","article-title":"Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin","volume":"24","author":"Moreira","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2006.06.006_bib7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1212\/01.WNL.0000151853.50144.82","article-title":"Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J","volume":"64","author":"Udd","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2006.06.006_bib8","first-page":"130","article-title":"Limb-girdle muscular dystrophies: Heterogeneity of clinical phenotypes and pathogenetic mechanisms","volume":"23","author":"Angelini","year":"2004","journal-title":"Acta Myol"},{"key":"10.1016\/j.spen.2006.06.006_bib9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/sj.ejhg.5201289","article-title":"A new form of autosomal dominant limb-girdle muscular dystrophy (LGMD1G) with progressive fingers and toes flexion limitation maps to chromosome 4p21","volume":"12","author":"Starling","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.spen.2006.06.006_bib10","first-page":"35","article-title":"Molecular bases of autosomal recessive limb-girdle muscular dystrophies","volume":"22","author":"Nigro","year":"2003","journal-title":"Acta Myol"},{"key":"10.1016\/j.spen.2006.06.006_bib11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/humu.20119","article-title":"Molecular and muscle pathology in a series of caveolinopathy patients","volume":"25","author":"Fulizio","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.spen.2006.06.006_bib12","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1136\/jmg.2003.013953","article-title":"FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients","volume":"41","author":"Walter","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.spen.2006.06.006_bib13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/01.wco.0000183947.01362.fe","article-title":"Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders","volume":"18","author":"Mercuri","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.spen.2006.06.006_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.nmd.2004.10.008","article-title":"Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures","volume":"15","author":"Mercuri","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2006.06.006_bib15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00415-005-0684-4","article-title":"Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs","volume":"252","author":"Fischer","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.spen.2006.06.006_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ajmg.a.30809","article-title":"550delA mutation in the calpain 3 (CAPN3) gene: DMD\/BMD, SMA, or LGMD2A\u2014Clinically misdiagnosed cases","volume":"136","author":"Georgieva","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.spen.2006.06.006_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1385\/JMN:21:3:233","article-title":"Calpainopathy: How broad is the spectrum of clinical variability?","volume":"21","author":"Starling","year":"2003","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.spen.2006.06.006_bib18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00019052-200410000-00005","article-title":"Laminopathies: From the heart of the cell to the clinics","volume":"17","author":"Benedetti","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.spen.2006.06.006_bib19","first-page":"104","article-title":"Laminopathies affecting skeletal and cardiac muscles: Clinical and pathophysiological aspects","volume":"24","author":"Decostre","year":"2005","journal-title":"Acta Myol"},{"key":"10.1016\/j.spen.2006.06.006_bib20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.yexcr.2004.11.020","article-title":"Both lamin A and lamin C mutations cause lamina instability as well as loss of internal nuclear lamin organization","volume":"304","author":"Broers","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.spen.2006.06.006_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/humu.20315","article-title":"A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria syndrome (HGPS): Insights into the pathophysiology of HGPS","volume":"27","author":"Denecke","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.spen.2006.06.006_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1399-0004.2004.00315.x","article-title":"Hutchinson-Gilford progeria syndrome","volume":"66","author":"Pollex","year":"2004","journal-title":"Clin Genet"},{"key":"10.1016\/j.spen.2006.06.006_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1399-0004.2005.00447.x","article-title":"LMNA mutation position predicts organ system involvement in laminopathies","volume":"68","author":"Hegele","year":"2005","journal-title":"Clin Genet"},{"key":"10.1016\/j.spen.2006.06.006_bib24","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/mus.20293","article-title":"Extreme variability of skeletal and cardiac muscle involvement in patients with mutations in exon 11 of the lamin A\/C gene","volume":"31","author":"Mercuri","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.spen.2006.06.006_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMc052632","article-title":"Primary prevention of sudden death in patients with lamin A\/C gene mutations","volume":"354","author":"Meune","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2006.06.006_bib26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejheart.2005.11.004","article-title":"Genetic and phenotypic analysis of dilated cardiomyopathy with conduction system disease: Demand for strategies in the management of presymptomatic lamin A\/C mutant carriers","volume":"8","author":"Perrot","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.spen.2006.06.006_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.hco.0000221575.33501.58","article-title":"Lamin A\/C and cardiac diseases","volume":"21","author":"Sylvius","year":"2006","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.spen.2006.06.006_bib28","first-page":"891","article-title":"Genetic localization of a newly recognized autosomal dominant limb- girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21","volume":"60","author":"van der Kooi","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2006.06.006_bib29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/302869","article-title":"Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy","volume":"66","author":"Raffaele Di Barletta","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2006.06.006_bib30","doi-asserted-by":"crossref","first-page":"25632","DOI":"10.1074\/jbc.274.36.25632","article-title":"Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C)","volume":"274","author":"Galbiati","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.spen.2006.06.006_bib31","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1212\/WNL.62.4.538","article-title":"Caveolinopathies: Mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases","volume":"62","author":"Woodman","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2006.06.006_bib32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/mus.20092","article-title":"Phenotypic variability associated with Arg26Gln mutation in caveolin3","volume":"30","author":"Fee","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.spen.2006.06.006_bib33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng0498-365","article-title":"Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy","volume":"18","author":"Minetti","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2006.06.006_bib34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.nmd.2004.01.006","article-title":"A novel mutation in the caveolin-3 gene causing familial isolated hyperCKaemia","volume":"14","author":"Alias","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2006.06.006_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/jnnp.73.1.65","article-title":"Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene","volume":"73","author":"Merlini","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.spen.2006.06.006_bib36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbrc.2003.11.101","article-title":"Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy","volume":"313","author":"Hayashi","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.spen.2006.06.006_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.20350","article-title":"Autosomal recessive rippling muscle disease with homozygous CAV3 mutations","volume":"57","author":"Kubisch","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2006.06.006_bib38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.10501","article-title":"Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease","volume":"53","author":"Kubisch","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2006.06.006_bib39","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1002\/mus.10156","article-title":"Rippling muscle disease: A review","volume":"11","author":"Torbergsen","year":"2002","journal-title":"Muscle Nerve Suppl"},{"key":"10.1016\/j.spen.2006.06.006_bib40","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/514896","article-title":"Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23","volume":"61","author":"Messina","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2006.06.006_bib41","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1212\/01.WNL.0000073984.46546.4F","article-title":"A novel autosomal dominant limb-girdle muscular dystrophy (LGMD 1F) maps to 7q32.1-32.2","volume":"61","author":"Palenzuela","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2006.06.006_bib42","doi-asserted-by":"crossref","first-page":"15457","DOI":"10.1074\/jbc.R200031200","article-title":"Dystrophin-glycoprotein complex: Post-translational processing and dystroglycan function","volume":"278","author":"Michele","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.spen.2006.06.006_bib43","doi-asserted-by":"crossref","first-page":"R259","DOI":"10.1093\/hmg\/ddg272","article-title":"Glycosylation defects: A new mechanism for muscular dystrophy?","volume":"12","author":"Grewal","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2006.06.006_bib44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s000180300020","article-title":"Glycosylation defects in inherited muscle disease","volume":"60","author":"Hewitt","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.spen.2006.06.006_bib45","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/jmg.38.10.649","article-title":"The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: Case series and review","volume":"38","author":"Jones","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.spen.2006.06.006_bib46","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1093\/hmg\/9.13.2019","article-title":"Molecular and genetic characterization of sarcospan: Insights into sarcoglycan-sarcospan interactions","volume":"9","author":"Crosbie","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2006.06.006_bib47","doi-asserted-by":"crossref","first-page":"10723","DOI":"10.1073\/pnas.96.19.10723","article-title":"Muscle degeneration without mechanical injury in sarcoglycan deficiency","volume":"96","author":"Hack","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.spen.2006.06.006_bib48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0959-437X(02)00309-X","article-title":"Muscular dystrophies involving the dystrophin-glycoprotein complex: An overview of current mouse models","volume":"12","author":"Durbeej","year":"2002","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.spen.2006.06.006_bib49","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1050-1738(03)00101-4","article-title":"Sarcoglycans in vascular smooth and striated muscle","volume":"13","author":"Wheeler","year":"2003","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.spen.2006.06.006_bib50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/humu.20110","article-title":"The most common mutation in FKRP causing limb girdle muscular dystrophy type 2I (LGMD2I) may have occurred only once and is present in Hutterites and other populations","volume":"25","author":"Frosk","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.spen.2006.06.006_bib51","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/ana.20283","article-title":"Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I","volume":"56","author":"Poppe","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2006.06.006_bib52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.nmd.2005.01.013","article-title":"An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburg syndrome (WWS) caused by a mutation in the POMT1 gene","volume":"15","author":"Balci","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2006.06.006_bib53","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0960-8966(03)00161-5","article-title":"A novel form of recessive limb girdle muscular dystrophy with mental retardation and abnormal expression of alpha-dystroglycan","volume":"13","author":"Dincer","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2006.06.006_bib54","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/brain\/121.4.581","article-title":"Abnormal merosin in adults","volume":"121","author":"Bushby","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.spen.2006.06.006_bib55","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/ana.20824","article-title":"High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 2I in Denmark","volume":"59","author":"Sveen","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2006.06.006_bib56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0092-8674(95)90368-2","article-title":"Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A","volume":"81","author":"Richard","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.spen.2006.06.006_bib57","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/brain\/awh408","article-title":"LGMD2A: Genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene","volume":"128","author":"Saenz","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.spen.2006.06.006_bib58","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1128\/MCB.23.24.9127-9135.2003","article-title":"Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components","volume":"23","author":"Taveau","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.spen.2006.06.006_bib59","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/978-1-4615-4267-4_23","article-title":"Skeletal muscle-specific calpain, p94, and connectin\/titin: Their physiological functions and relationship to limb-girdle muscular dystrophy type 2A","volume":"481","author":"Sorimachi","year":"2000","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.spen.2006.06.006_bib60","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/302426","article-title":"Calpainopathy\u2014A survey of mutations and polymorphisms","volume":"64","author":"Richard","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2006.06.006_bib61","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0960-8966(00)00197-8","article-title":"The phenotype of calpainopathy: Diagnosis based on a multidisciplinary approach","volume":"11","author":"Pollitt","year":"2001","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2006.06.006_bib62","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature01573","article-title":"Defective membrane repair in dysferlin-deficient muscular dystrophy","volume":"423","author":"Bansal","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.spen.2006.06.006_bib63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/humu.9355","article-title":"Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies","volume":"26","author":"Nguyen","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.spen.2006.06.006_bib64","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00415-003-0234-x","article-title":"Variable reduction of caveolin-3 in patients with LGMD2B\/MM","volume":"250","author":"Walter","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.spen.2006.06.006_bib65","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0960-8966(00)00143-7","article-title":"Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies)","volume":"10","author":"Anderson","year":"2000","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2006.06.006_bib66","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/jcp.2004.018978","article-title":"Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism","volume":"58","author":"Cenacchi","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.spen.2006.06.006_bib67","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.20441","article-title":"Commonality of TRIM32 mutation in causing sarcotubular myopathy and LGMD2H","volume":"57","author":"Schoser","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2006.06.006_bib68","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1212\/WNL.56.7.869","article-title":"Secondary calpain3 deficiency in 2q-linked muscular dystrophy: Titin is the candidate gene","volume":"56","author":"Haravuori","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2006.06.006_bib69","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/01.wco.0000181326.86292.aa","article-title":"Nonmolecular treatment for muscular dystrophies","volume":"18","author":"Bushby","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.spen.2006.06.006_bib70","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0960-8966(02)00213-4","article-title":"107th ENMC international workshop: The management of cardiac involvement in muscular dystrophy and myotonic dystrophy, 7th-9th June 2002, Naarden, the Netherlands","volume":"13","author":"Bushby","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2006.06.006_bib71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nmd.2003.09.003","article-title":"ENMC workshop: Ventilatory support in congenital neuromuscular disorders\u2014Congenital myopathies, congenital muscular dystrophies, congenital myotonic dystrophy and SMA (II) 4-6 April 2003, Naarden, The Netherlands","volume":"14","author":"Wallgren-Pettersson","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2006.06.006_bib72","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.apmr.2004.11.028","article-title":"Chronic pain in persons with neuromuscular disease","volume":"86","author":"Jensen","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.spen.2006.06.006_bib73","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0960-8966(02)00136-0","article-title":"Report on the muscular dystrophy campaign workshop: Exercise in neuromuscular diseases, Newcastle, January 2002","volume":"12","author":"Eagle","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2006.06.006_bib74","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nmd.2004.10.017","article-title":"Complications of anaesthesia in neuromuscular disorders","volume":"15","author":"Klingler","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2006.06.006_bib75","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nmd.2005.10.001","article-title":"Facing the genetic heterogeneity in neuromuscular disorders: linkage analysis as an economic diagnostic approach towards the molecular diagnosis","volume":"16","author":"von der Hagen","year":"2006","journal-title":"Neuromuscul Disord"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909106000969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909106000969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T09:51:15Z","timestamp":1547286675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909106000969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S1071909106000969"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2006.06.006","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}